JP2005508308A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508308A5 JP2005508308A5 JP2003517034A JP2003517034A JP2005508308A5 JP 2005508308 A5 JP2005508308 A5 JP 2005508308A5 JP 2003517034 A JP2003517034 A JP 2003517034A JP 2003517034 A JP2003517034 A JP 2003517034A JP 2005508308 A5 JP2005508308 A5 JP 2005508308A5
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- ethoxy
- pharmaceutical composition
- methyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C(C(CCc1c2*)c1cc(*)c2O)C(O*)=O Chemical compound *C(C(CCc1c2*)c1cc(*)c2O)C(O*)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30850001P | 2001-07-27 | 2001-07-27 | |
| US37304802P | 2002-04-16 | 2002-04-16 | |
| PCT/US2002/023614 WO2003011842A1 (en) | 2001-07-27 | 2002-07-25 | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005508308A JP2005508308A (ja) | 2005-03-31 |
| JP2005508308A5 true JP2005508308A5 (https=) | 2006-01-05 |
| JP4510447B2 JP4510447B2 (ja) | 2010-07-21 |
Family
ID=26976280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003517034A Expired - Fee Related JP4510447B2 (ja) | 2001-07-27 | 2002-07-25 | インダン酢酸誘導体および医薬としてのそれらの使用、中間体および製法 |
Country Status (32)
| Country | Link |
|---|---|
| US (4) | US6828335B2 (https=) |
| EP (1) | EP1414809B1 (https=) |
| JP (1) | JP4510447B2 (https=) |
| KR (2) | KR100956898B1 (https=) |
| CN (1) | CN100528850C (https=) |
| AR (1) | AR036237A1 (https=) |
| AT (1) | ATE388944T1 (https=) |
| AU (2) | AU2002319693B2 (https=) |
| BR (1) | BR0211502A (https=) |
| CA (2) | CA2455620C (https=) |
| CO (1) | CO5560561A2 (https=) |
| CY (1) | CY1107370T1 (https=) |
| DE (1) | DE60225561T2 (https=) |
| DK (1) | DK1414809T3 (https=) |
| ES (1) | ES2302825T3 (https=) |
| HR (1) | HRP20040076A2 (https=) |
| HU (1) | HUP0700105A2 (https=) |
| IL (3) | IL159960A0 (https=) |
| MA (1) | MA27063A1 (https=) |
| MX (1) | MXPA04000599A (https=) |
| MY (1) | MY139541A (https=) |
| NO (2) | NO20040356L (https=) |
| NZ (1) | NZ531351A (https=) |
| PE (1) | PE20030326A1 (https=) |
| PL (1) | PL374383A1 (https=) |
| PT (1) | PT1414809E (https=) |
| RU (1) | RU2314298C2 (https=) |
| SI (1) | SI1414809T1 (https=) |
| SV (1) | SV2003001186A (https=) |
| TW (2) | TWI345563B (https=) |
| UY (1) | UY27392A1 (https=) |
| WO (1) | WO2003011842A1 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110065129A1 (en) * | 2001-07-27 | 2011-03-17 | Lowe Derek B | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| AR036237A1 (es) * | 2001-07-27 | 2004-08-25 | Bayer Corp | Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento |
| US6867224B2 (en) | 2002-03-07 | 2005-03-15 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods of preparation |
| US6833380B2 (en) | 2002-03-07 | 2004-12-21 | Warner-Lambert Company, Llc | Compounds that modulate PPAR activity and methods of preparation |
| UA79755C2 (en) * | 2002-04-16 | 2007-07-25 | Bayer Pharmaceuticals Corp | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| WO2004011446A1 (en) * | 2002-07-26 | 2004-02-05 | Bayer Pharmaceuticals Corporation | Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics |
| EP1578715B1 (en) | 2002-12-20 | 2011-03-02 | Bayer Pharmaceuticals Corporation | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| US7244763B2 (en) * | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| EP1630152A4 (en) | 2003-05-30 | 2009-09-23 | Takeda Pharmaceutical | CONDENSED CYCLIC COMPOUND |
| WO2005110394A1 (ja) * | 2004-05-19 | 2005-11-24 | Ajinomoto Co., Inc. | 糖尿病治療薬 |
| JP2008510696A (ja) * | 2004-08-20 | 2008-04-10 | カディラ ヘルスケア リミティド | 新規抗糖尿病化合物 |
| JPWO2006057448A1 (ja) * | 2004-11-26 | 2008-06-05 | 武田薬品工業株式会社 | アリールアルカン酸誘導体 |
| PL1954684T3 (pl) * | 2005-11-15 | 2014-10-31 | Otsuka Pharma Co Ltd | Związek oksazolowy i kompozycja farmaceutyczna |
| KR20080103584A (ko) | 2006-03-30 | 2008-11-27 | 아사히 가세이 파마 가부시키가이샤 | 치환 이환식 환상 유도체 및 그 용도 |
| GB0712653D0 (en) | 2007-06-28 | 2007-08-08 | Syngenta Ltd | Novel herbicides |
| GB0717082D0 (en) | 2007-09-03 | 2007-10-10 | Syngenta Ltd | Novel herbicides |
| CN104710365A (zh) | 2008-04-28 | 2015-06-17 | 旭化成制药株式会社 | 苯丙酸衍生物及其用途 |
| CN102065900B (zh) * | 2008-06-23 | 2013-09-25 | 东亚荣养株式会社 | 经皮吸收促进剂和使用其的经皮给药制剂 |
| EA022417B1 (ru) * | 2008-10-21 | 2015-12-30 | Саймабэй Терапевтикс, Инк. | Арильные агонисты рецептора gpr120 и их применение |
| US8633252B2 (en) * | 2009-01-26 | 2014-01-21 | Taipei Medical University | Use of pterosin compounds for treating diabetes and obesity |
| AR075401A1 (es) * | 2009-02-13 | 2011-03-30 | Sanofi Aventis | Indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento |
| WO2010141690A2 (en) * | 2009-06-04 | 2010-12-09 | Dara Biosciences, Inc. | Indane analogs and use as pharmaceutical agents and process of making |
| US20180200230A1 (en) * | 2009-06-04 | 2018-07-19 | Dara Biosciences, Inc. | Methods of treating neurodegenerative diseases using indane acetic acid derivatives which penetrate the blood brain barrier |
| WO2010141696A1 (en) * | 2009-06-04 | 2010-12-09 | Dara Biosciences, Inc. | Methods of treating or preventing psoriasis, and/or alzheimer's disease using indane acetic acid derivatives |
| EP2473515A4 (en) | 2009-09-04 | 2013-11-27 | Univ Toledo | PROCESS FOR PREPARING OPTICALLY PURE BETA LACTONS FROM ALDEHYDE AND COMPOSITIONS MADE THEREOF |
| WO2012074980A2 (en) * | 2010-12-01 | 2012-06-07 | Dara Biosciences, Inc. | Methods of treating or preventing autoimmune disorders and liver disorders using indane acetic acid derivatives |
| CA2980296A1 (en) * | 2015-03-26 | 2016-09-29 | T3D Therapeutics, Inc. | Methods of treating liver disease using indane acetic acid derivatives |
| TWI712582B (zh) * | 2015-10-14 | 2020-12-11 | 法商領先藥物公司 | 用來製備(5s,10s)-10-苄基-16-甲基-11,14,18-三側氧基-15,17,19-三氧雜-2,7,8-三噻基-12-氮二十一烷基-5-銨基(e)-3-羧基丙烯酸鹽的工業方法 |
| US20180153860A1 (en) * | 2016-12-02 | 2018-06-07 | T3D Therapeutics, Inc. | Methods of dose administration for treating or preventing cognitive impairment using indane acetic acid derivatives |
| US20180153859A1 (en) * | 2016-12-02 | 2018-06-07 | T3D Therapeutics, Inc. | Methods of treating or preventing cognitive impairment using indane acetic acid derivatives based on apoe4 genotype |
| US10919852B2 (en) | 2017-07-28 | 2021-02-16 | Chemocentryx, Inc. | Immunomodulator compounds |
| CA3113689A1 (en) | 2018-09-25 | 2020-04-02 | Antabio Sas | Indane derivatives for use in the treatment of bacterial infection |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3929923A (en) * | 1972-01-17 | 1975-12-30 | Sun Research Development | Process for preparation of isomers of 1-cyclohexyl-1,3,3-trimethylhydrindane |
| US4754043A (en) * | 1985-10-03 | 1988-06-28 | American Home Products Corporation | Oxazole and thiazole naphthalenes as antiallergic agents |
| FR2670491B1 (fr) * | 1990-12-14 | 1993-02-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| US5480896A (en) | 1994-01-27 | 1996-01-02 | American Home Products Corporation | Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents |
| US5939442A (en) | 1995-06-07 | 1999-08-17 | The Salk Institute For Biological Studies | Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof |
| JPH1087602A (ja) * | 1996-09-09 | 1998-04-07 | Zeria Pharmaceut Co Ltd | スルホンアミド誘導体、それを含有するトロンボキサン拮抗剤及び該化合物の製造中間体 |
| WO1999011255A1 (en) * | 1997-08-28 | 1999-03-11 | Ono Pharmaceutical Co., Ltd. | Peroxisome proliferator-activated receptor controllers |
| PL351470A1 (en) | 1999-04-28 | 2003-04-22 | Aventis Pharma Gmbh | Tri-aryl acid derivatives as ppar receptor ligands |
| YU72201A (sh) | 1999-04-28 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | Derivati di-aril kiseline kao ppar receptorski ligandi |
| US6417212B1 (en) * | 1999-08-27 | 2002-07-09 | Eli Lilly & Company | Modulators of peroxisome proliferator activated receptors |
| JP2004509084A (ja) | 2000-08-23 | 2004-03-25 | イーライ・リリー・アンド・カンパニー | オキサゾリル−アリールオキシ酢酸誘導体およびそのｐｐａｒアゴニストとしての使用 |
| AR036237A1 (es) * | 2001-07-27 | 2004-08-25 | Bayer Corp | Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento |
-
2002
- 2002-07-19 AR ARP020102731A patent/AR036237A1/es unknown
- 2002-07-23 UY UY27392A patent/UY27392A1/es unknown
- 2002-07-25 MY MYPI20022806A patent/MY139541A/en unknown
- 2002-07-25 DE DE60225561T patent/DE60225561T2/de not_active Expired - Lifetime
- 2002-07-25 MX MXPA04000599A patent/MXPA04000599A/es active IP Right Grant
- 2002-07-25 DK DK02750297T patent/DK1414809T3/da active
- 2002-07-25 HU HU0700105A patent/HUP0700105A2/hu unknown
- 2002-07-25 IL IL15996002A patent/IL159960A0/xx unknown
- 2002-07-25 JP JP2003517034A patent/JP4510447B2/ja not_active Expired - Fee Related
- 2002-07-25 NZ NZ531351A patent/NZ531351A/en not_active IP Right Cessation
- 2002-07-25 KR KR1020047001188A patent/KR100956898B1/ko not_active Expired - Fee Related
- 2002-07-25 BR BR0211502-6A patent/BR0211502A/pt not_active IP Right Cessation
- 2002-07-25 CN CNB028186761A patent/CN100528850C/zh not_active Expired - Fee Related
- 2002-07-25 ES ES02750297T patent/ES2302825T3/es not_active Expired - Lifetime
- 2002-07-25 PE PE2002000661A patent/PE20030326A1/es not_active Application Discontinuation
- 2002-07-25 EP EP02750297A patent/EP1414809B1/en not_active Expired - Lifetime
- 2002-07-25 CA CA2455620A patent/CA2455620C/en not_active Expired - Lifetime
- 2002-07-25 KR KR1020097023801A patent/KR100987267B1/ko not_active Expired - Fee Related
- 2002-07-25 SI SI200230691T patent/SI1414809T1/sl unknown
- 2002-07-25 PT PT02750297T patent/PT1414809E/pt unknown
- 2002-07-25 US US10/205,839 patent/US6828335B2/en not_active Expired - Lifetime
- 2002-07-25 WO PCT/US2002/023614 patent/WO2003011842A1/en not_active Ceased
- 2002-07-25 RU RU2004105925/04A patent/RU2314298C2/ru active
- 2002-07-25 HR HR20040076A patent/HRP20040076A2/hr not_active Application Discontinuation
- 2002-07-25 AT AT02750297T patent/ATE388944T1/de active
- 2002-07-25 AU AU2002319693A patent/AU2002319693B2/en not_active Expired
- 2002-07-25 PL PL02374383A patent/PL374383A1/xx unknown
- 2002-07-25 CA CA2753329A patent/CA2753329A1/en not_active Abandoned
- 2002-07-26 SV SV2002001186A patent/SV2003001186A/es not_active Application Discontinuation
- 2002-07-26 TW TW099108854A patent/TWI345563B/zh not_active IP Right Cessation
- 2002-07-26 TW TW091116663A patent/TWI328008B/zh not_active IP Right Cessation
-
2004
- 2004-01-20 IL IL159960A patent/IL159960A/en unknown
- 2004-01-26 NO NO20040356A patent/NO20040356L/no not_active Application Discontinuation
- 2004-02-23 CO CO04015672A patent/CO5560561A2/es not_active Application Discontinuation
- 2004-02-27 MA MA27553A patent/MA27063A1/fr unknown
- 2004-09-22 US US10/949,119 patent/US7112597B2/en not_active Expired - Lifetime
-
2006
- 2006-05-05 US US11/429,136 patent/US7358386B2/en not_active Expired - Lifetime
-
2008
- 2008-03-27 CY CY20081100353T patent/CY1107370T1/el unknown
- 2008-03-31 US US12/059,706 patent/US20090047687A1/en not_active Abandoned
- 2008-08-04 NO NO20083411A patent/NO20083411L/no not_active Application Discontinuation
- 2008-10-29 AU AU2008237581A patent/AU2008237581A1/en not_active Abandoned
-
2010
- 2010-10-24 IL IL208891A patent/IL208891A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508308A5 (https=) | ||
| CA2455620A1 (en) | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation | |
| CN1124488A (zh) | 新的噻唑烷二酮及含有这些化合物的药剂 | |
| JP2008509982A5 (https=) | ||
| JP5119924B2 (ja) | 含窒素複素環化合物およびその医薬用途 | |
| Hulin et al. | Hypoglycemic activity of a series of α-alkylthio and α-alkoxy carboxylic acids related to ciglitazone | |
| RU2383524C2 (ru) | Гексафторизопропанол-замещенные производные простых эфиров | |
| AU2004229418B2 (en) | Compounds for the treatment of metabolic disorders | |
| JP2005527625A5 (https=) | ||
| CN1212622A (zh) | 应用PPARα或PPARγ拮抗剂治疗X综合征 | |
| CN1152025C (zh) | 取代的苄基噻唑烷-2,4-二酮衍生物 | |
| US20120141483A1 (en) | Methods of treating or preventing psoriasis, and/or alzheimer's disease using indane acetic acid derivatives | |
| CN1230114A (zh) | Leptine抵抗的新疗法 | |
| JP2010520873A (ja) | ペルオキシソーム増殖因子活性化γ受容体調節因子としての新規フェニルプロピオン酸誘導体、その方法およびそれを含む医薬組成物 | |
| JP2022504298A5 (https=) | ||
| WO2007085135A1 (en) | 1,3-benzodioxolecyclopentene-2,2-dicarboxylic acid derivates, preparation process and medical uses thereof | |
| CN1307166C (zh) | HPPAR－α受体的噁唑/噻唑衍生物活化剂 | |
| RU2355682C2 (ru) | Антидиабетические оксазолидиндионы | |
| JP2005526834A5 (https=) | ||
| Ortiz et al. | Synthetic thiazolidinediones: potential antidiabetic compounds | |
| RU2006102866A (ru) | Тиазолзамещенные индолилпроизводные и их применение в качестве модуляторов ppar | |
| EP1854784A1 (en) | Activator for peroxisome proliferator activating receptor | |
| ZA200401517B (en) | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation. | |
| CN1319956C (zh) | 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用 | |
| Ghosha et al. | Advances in the chemistry of thiazolidinediones as antidiabetic agents t |